Skip to main content

Cholestyramine for Oral Suspension

NDC 62135-008 · Chartwell RX, LLC

Generic nameCholestyramine for Oral Suspension
Dosage formPOWDER
RouteORAL
Active ingredient(s)CHOLESTYRAMINE
Strength4 g/9g
Pharmacologic classBile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]
Marketing categoryANDA

Packages

62135-008-56 — 378 g in 1 CAN (62135-008-56)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

42806-267 — cholestyramine, 42806-269 — cholestyramine light, 42806-270 — cholestyramine light, 42806-271 — cholestyramine light, 49884-465 — cholestyramine, 49884-466 — cholestyramine, 49884-936 — Cholestyramine, 49884-937 — Cholestyramine, 51224-009 — Cholestyramine, 51224-011 — Cholestyramine, 62135-937 — Cholestyramine for Oral Suspension, 63629-2162 — cholestyramine, 63629-2164 — cholestyramine, 63629-9196 — cholestyramine powder for suspension, 63629-9466 — Choleystyramine Light, 67877-298 — cholestyramine powder for suspension, 67877-422 — Choleystyramine Light, 68094-806 — Cholestyramine, 68094-906 — Cholestyramine, 68382-528 — CHOLESTYRAMINE, +17 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels